Metabolic liver disease in new HIV patients
Part of Digestive system, Hormones & metabolism, Immune system & allergy, Infections clinical trials.
This study looks at liver health in people newly diagnosed with HIV, before they start HIV treatment. It aims to understand early changes in the liver related to metabolism.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a citizen of Türkiye
- You are 18 years or older
- You have been newly diagnosed with HIV (confirmed positive)
- You are about to start or have just started HIV medications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how diet and lifestyle affect liver health and heart risk in people with HIV. It may help find ways to prevent or manage liver fat buildup.
This study looks at a new non-invasive screening method to predict metabolic dysfunction–associated steatotic liver disease (MASLD), a condition where fat builds up in the liver. The goal is to help identify people who may be at risk without needing invasive tests.
This study tests a new ultrasound device that uses sound waves to measure fat in the liver without needles or surgery. It is for people with a type of fatty liver disease called MASLD or MASH, who are already getting an MRI to check their liver.
This study looks at fat buildup in the liver (fatty liver disease) in people with and without HIV. It uses blood tests to understand the liver's fat content and how it relates to HIV, which may help improve future care.
This study tests a new drug called ALN-CIDEB for people with fatty liver disease (MASLD or MASH). The goal is to see if it can reduce liver fat and improve liver health. You may qualify if you have a higher BMI and evidence of liver fat on imaging tests.
This study tests a new blood test to help diagnose fatty liver disease and liver fibrosis. It aims to see how well the test works compared with a liver biopsy. Your participation could help improve diagnosis for others.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.